Do Asymptomatic Babies With Congenital CMV Need Antivirals?
At a Glance
Babies with congenital CMV who have a completely normal physical exam, bloodwork, brain imaging, eye exam, and diagnostic hearing evaluation usually do not receive antiviral medicine. They need scheduled hearing and developmental follow-up because hearing loss can appear later.
If your baby has been diagnosed with congenital cytomegalovirus (cCMV) (typically confirmed by a saliva or urine test within the first 21 days of life) but currently has no identified signs of the infection—including a completely normal physical evaluation, bloodwork, brain imaging, and hearing—they typically do not need antiviral medication [1]. Current medical guidelines do not routinely recommend treatment for truly asymptomatic babies because the potential risks of the medications currently outweigh the unproven benefits [1]. Instead of medication, the standard of care is structured, long-term monitoring to catch and manage any issues that might develop later, particularly hearing loss [1][2]. Choosing observation for a truly asymptomatic baby is an active care plan, not neglect.
Why Medication is Not the First Step for Asymptomatic Babies
Antiviral medications used to treat cCMV, such as valganciclovir and ganciclovir, are medicines with potentially significant adverse effects. While the evidence shows they are beneficial for babies born with symptomatic cCMV, especially those with central nervous system (brain) involvement [3][4], they carry significant risks that are not justified for babies with no abnormalities on their initial evaluation [1].
The most common and serious side effect is neutropenia, a condition where the bone marrow produces too few neutrophils (a type of white blood cell essential for fighting off bacterial infections) [5][6]. Treatment can also cause anemia (low red blood cells) [7]. Because of these risks, babies on these medications require frequent blood draws to monitor their blood counts, kidney function, and liver function [8]. For a baby who currently has no identified signs of disease, exposing them to these side effects and frequent blood tests without a proven medical benefit is generally not recommended [1].
What Does “Truly Asymptomatic” Mean?
It is very important that your medical team determines whether your baby is truly asymptomatic. Being asymptomatic means much more than just looking well from the outside. A complete, clinician-directed medical evaluation to confirm your baby does not have symptoms typically involves:
- A thorough physical examination (checking for signs like jaundice, a rash called petechiae, or an enlarged liver or spleen)
- Normal laboratory results (checking liver function and blood counts like platelets)
- Normal brain imaging (often starting with a cranial ultrasound; an MRI may be ordered by a specialist if there are specific concerns)
- A comprehensive diagnostic audiology evaluation by an audiologist (a hearing specialist). This is a detailed test, such as an Auditory Brainstem Response (ABR) test, not just the basic newborn hearing screen.
- An eye exam by an ophthalmologist (a medical eye specialist) [9][10][1].
A Note on Isolated Hearing Loss: If a baby looks well and has normal physical, lab, and brain scan results, but does have sensorineural hearing loss (hearing loss involving the inner ear or the hearing nerve) caused by cCMV, they are not considered asymptomatic. Treatment for this specific group is currently debated among medical experts [4][1]. Studies on whether antivirals improve or protect hearing in these babies have shown mixed results, so treatment decisions are individualized and made on a case-by-case basis with a pediatric infectious disease specialist and an audiologist [11][12]. Any abnormal finding requires prompt review by a specialist.
The Critical Need for Long-Term Monitoring
Even if your baby does not need medication right now, they still require structured, ongoing follow-up. A normal newborn hearing screen does not mean your baby is clear of future risks [2].
Babies with asymptomatic cCMV are at risk for late-onset, progressive, or fluctuating hearing loss that can develop months or even years after birth [13][14]. While most asymptomatic infants do not develop hearing loss, continuous surveillance is essential because missing a change has important consequences [2]. If hearing loss does occur, interventions (such as hearing aids, evaluating for cochlear implants when appropriate, or speech-language services) can be started immediately [15].
Because hearing loss can happen at any time, your child’s audiologist and care team will create a specific monitoring schedule. While protocols differ by clinic, they often involve testing every 3 to 6 months during the first few years of life, and then about every 6 months to a year until your child reaches early childhood (around age 6) [2][16][17].
Alongside hearing checks, developmental surveillance is part of routine pediatric care to ensure they are meeting their milestones [17][9]. If you ever notice a change in your child’s hearing, speech, or development between scheduled appointments, do not wait for the next annual visit—contact your care team immediately.
Disclaimer: This information is for educational purposes. Do not use this page to decide if your child is eligible for treatment. Always follow the guidance of your child’s pediatrician, pediatric infectious disease specialist, and audiologist.
Common questions in this guide
Do babies with completely asymptomatic congenital CMV usually need antiviral medicine?
How do doctors determine whether a baby with congenital CMV is truly asymptomatic?
What if my baby with congenital CMV has hearing loss but no other findings?
Can hearing loss develop later if my baby with congenital CMV hears normally at birth?
How often should a baby with asymptomatic congenital CMV have hearing tests?
What should I do if I notice a change in my child's hearing, speech, or development?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Related questions
Show more
Get notified when new evidence is published on Cytomegalovirus Infection.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Has my baby had a full diagnostic audiology evaluation (like an ABR) to confirm they have normal hearing, rather than just the standard newborn hearing screen?
- 2.What specific tests (such as a cranial ultrasound, bloodwork, or an eye exam) still need to be completed by our care team to ensure my baby has no hidden signs of cCMV?
- 3.What is your recommended schedule for my baby's follow-up hearing tests over the next several years?
- 4.If my baby's hearing does change in the future, what are the immediate next steps, and who should I contact first?
References
References (17)
- 1
"Minimally symptomatic" congenital cytomegalovirus infection: latest data and emerging concepts.
Howard A, Nishikawa JK, Sánchez PJ
Current opinion in pediatrics 2024; (36(4)):480-488 doi:10.1097/MOP.0000000000001364.
PMID: 38747205 - 2
Prognostic Factors of Late-onset Hearing Loss in Infants With Congenital Cytomegalovirus and Normal Audiologic Assessment at Birth.
Buonsenso D, Pedrero-Tomé R, Raimondi F, et al.
The Pediatric infectious disease journal 2026; (45(1)):1-10 doi:10.1097/INF.0000000000004960.
PMID: 40838764 - 3
[Therapy Options for Infants with Congenital Cytomegalovirus Infection - Implications for Setting Up Neonatal Screening Programs].
Bührer C, Blankenstein O, Rossi R,
Zeitschrift fur Geburtshilfe und Neonatologie 2020; (224(2)):71-78 doi:10.1055/a-0966-9915.
PMID: 31426118 - 4
Potential Benefit of Selective CMV Testing after Failed Newborn Hearing Screening.
Kummer P, Marcrum SC
International journal of neonatal screening 2018; (4(2)):20 doi:10.3390/ijns4020020.
PMID: 33072943 - 5
Valganciclovir for symptomatic congenital cytomegalovirus disease.
Kimberlin DW, Jester PM, Sánchez PJ, et al.
The New England journal of medicine 2015; (372(10)):933-43 doi:10.1056/NEJMoa1404599.
PMID: 25738669 - 6
Severe Neutropenia in Infants With Congenital Cytomegalovirus on Antiviral Therapy.
Papaevangelou V, Pedrero-Tomé R, Syridou G, et al.
The Pediatric infectious disease journal 2025; (44(11)):1044-1050 doi:10.1097/INF.0000000000004905.
PMID: 40674644 - 7
Hematologic Adverse Events Associated With Prolonged Valganciclovir Treatment in Congenital Cytomegalovirus Infection.
Ziv L, Yacobovich J, Pardo J, et al.
The Pediatric infectious disease journal 2019; (38(2)):127-130 doi:10.1097/INF.0000000000002079.
PMID: 29677086 - 8
Treatment of congenital cytomegalovirus infection.
Shim GH
Clinical and experimental pediatrics 2023; (66(9)):384-394 doi:10.3345/cep.2022.01032.
PMID: 36596746 - 9
Outcome and management of newborns with congenital cytomegalovirus infection.
Nicloux M, Peterman L, Parodi M, Magny JF
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2020; (27(3)):160-165 doi:10.1016/j.arcped.2020.01.006.
PMID: 32127242 - 10
Care of the Infant With Congenital Cytomegalovirus Infection: Clinical Report.
Tesini BL, Caserta MT, Park AH, et al.
Pediatrics 2026; (158(4)) doi:10.1542/peds.2026-078595.
PMID: 42764165 - 11
Valganciclovir in Infants with Hearing Loss and Clinically Inapparent Congenital Cytomegalovirus Infection: A Nonrandomized Controlled Trial.
Chung PK, Schornagel FAJ, Soede W, et al.
The Journal of pediatrics 2024; (268()):113945 doi:10.1016/j.jpeds.2024.113945.
PMID: 38336204 - 12
Oral Valganciclovir Initiated Beyond 1 Month of Age as Treatment of Sensorineural Hearing Loss Caused by Congenital Cytomegalovirus Infection: A Randomized Clinical Trial.
Kimberlin DW, Aban I, Peri K, et al.
The Journal of pediatrics 2024; (268()):113934 doi:10.1016/j.jpeds.2024.113934.
PMID: 38309519 - 13
Congenital cytomegalovirus infection inducing non-congenital sensorineural hearing loss during childhood; a systematic review.
Riga M, Korres G, Chouridis P, et al.
International journal of pediatric otorhinolaryngology 2018; (115()):156-164 doi:10.1016/j.ijporl.2018.10.005.
PMID: 30368378 - 14
The Natural History and Rehabilitative Outcomes of Hearing Loss in Congenital Cytomegalovirus: A Systematic Review.
Fletcher KT, Horrell EMW, Ayugi J, et al.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2018; (39(7)):854-864 doi:10.1097/MAO.0000000000001861.
PMID: 29912824 - 15
CMV-induced Hearing Loss.
Singh S, Maheshwari A, Boppana S
Newborn (Clarksville, Md.) 2023; (2(4)):249-262 doi:10.5005/jp-journals-11002-0081.
PMID: 38348106 - 16
Hearing and neurodevelopmental outcomes for children with asymptomatic congenital cytomegalovirus infection: A systematic review.
Bartlett AW, McMullan B, Rawlinson WD, Palasanthiran P
Reviews in medical virology 2017; doi:10.1002/rmv.1938.
PMID: 28876493 - 17
Follow-up of infants with congenital cytomegalovirus and normal fetal imaging.
Amir J, Atias J, Linder N, Pardo J
Archives of disease in childhood. Fetal and neonatal edition 2016; (101(5)):F428-32 doi:10.1136/archdischild-2015-308357.
PMID: 26782597
This page is for educational purposes only and does not constitute medical advice. Your baby's pediatrician, pediatric infectious disease specialist, and audiologist should determine the appropriate evaluation, treatment, and follow-up.